Conférences sur les essais cliniques 2023

The theme of the 7^th Annual Patient-Centered Approach to Clinical Trials Conference is: Embedding Cancer Clinical Trials Research into Clinical Practice.

Over the course of the past several years, we have made significant progress in fostering patient and patient group partnerships among researchers and stakeholders engaged in cancer clinical trials and their engagement in the clinical trial continuum.

Our objectives this year are:

• Lay out the case for embedding clinical trials into clinical practice
• Educate on how embedding clinical trials into clinical practice supports and builds a learning health system
• Explore, using the CTTI model as a foundation, how embedding clinical trials into clinical practice can be achieved in Canada
• Gain cross stakeholder perspective and input on barriers and facilitators to moving forward

Speakers: Barry Stein, President & CEO, Colorectal Cancer Canada, Anne-Marie Wright, President, Elements Strategy Inc.

Speaker: Dr. Francois Lamontagne, Clinician Scientist at Centre de Recherche du CHU de Sherbrooke.

Speaker: Megan Bettle, Executive Director, Clinical Trials Canadian Institutes of Health Research.

Speaker: Dr. Philippa Corrie, Consultant Medical Oncologist and Affiliated Associate Professor, University of Cambridge, NIHR Cancer National Specialty and Vaccines Research Programme Co-Lead. NIHR CRN National Specialty Lead for Cancer: Late Phase and International Trials.

Speakers: Dr. Kelvin Chan, Medical Oncologist, Sunnybrook Odette Cancer Center. Dr. Vishal Navani, Medical Oncologist. Tom Baker Cancer Center. Dr. Winson Cheung, Senior medical oncologist and real-word data scientist.

Speakers: Alan J. Forster, Executive Vice President, Chief Innovation and Quality Officer at the Ottawa Hospital. Dr. Henry Conter, Portfolio Manager in Early Development Clinical Oncology, Roche Global. Michael Duong, Ph.D., Head of Innovation, Hoffmann-La Roche. Shaneel Pathak, Co-founder and Chief Executive Officer, Zamplo Inc.

Speaker: Sara Bristol Calvert, Director of Projects, Clinical Trials Transformation Initiative (CTTI).

Speaker: Dr. Natalie Coburn, Senior Surgical Oncologist, Sunnybrook Health Sciences Centre.

Speaker: Barry Stein, President & CEO, Colorectal Cancer Canada.

Speaker: Barry Stein, President & CEO, CCC.

Speakers: Dr. Angie Marsh, Global Clinical Program Lead, Oncology R&D, AstraZeneca.

Speakers: Anne Marie Wright, President, Elements Strategy Inc. Dr. Anne-Marie Mes-Masson, Associate scientific director Basic and translational research, CRCHUM, Director Cancer research network, FRQS, Full professor Department of medicine, University of Montreal. Dr. Gerald Batist, Director, Segal Cancer Center, Jewish General Hospital. Karine-Iseult Ippersiel, President & CEO, Quebec Breast Cancer. Michael Duong, Ph.D., Head of Innovation, Hoffmann-La Roche. Sara Bristol Calvert, Director of Projects, Clinical Trials Transformation Initiative (CTTI)

Speakers: Dr. Fahad Razak, Internist, St. Michael’s Hospital. Dr. John Marshall, Canadian Lead Investigator, REMAP-CAP Trial. Dr. Srinivas Murthy, Investigator, BC Children’s Hospital. Nicole Yada, Director of Strategy & Operations for REMAP-CAP.

Workshop Forum

Speakers: Camille Leahy, Cancer Survivor & Patient Advocate. Dr. Manoj Lalu, Anesthesiologist & Scientist at The Ottawa Hospital. Dr. Stéphanie Michaud, President & CEO, BioCanRx. Dr. Stuart Nicholls, Strategy Lead for Patient-Oriented Research at Ottawa Hospital Research Institute. Linda Hunter, Patient Co-Investigator for the Clinical Trails Training Platform research grant funded by CIHR called CanTrain and is the national Co-Chair of the Patient, Family and Community Member Working Group.

Closing Remarks